BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 45 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 45 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
Market News

Lam Research Corp. (LRCX): Q1 2020 Earnings Snapshot

– Lam Research Corp. (NASDAQ: LRCX) reported first-quarter 2020 adjusted earnings of $3.18 per share, vs. $3.01 per share expected. – September-quarter unadjusted earnings were $3.09 per share, vs. $3.23 per share last year – Revenues declined 7% year-over-year to $2.17 billion, vs. $2.16 billion expected – Forecasts second-quarter revenues of $2.5 billion – Looking […]

$LRCX October 23, 2019 1 min read

– Lam Research Corp. (NASDAQ: LRCX) reported first-quarter 2020 adjusted earnings of $3.18 per share, vs. $3.01 per share expected.

– September-quarter unadjusted earnings were $3.09 per share, vs. $3.23 per share last year

– Revenues declined 7% year-over-year to $2.17 billion, vs. $2.16 billion expected

– Forecasts second-quarter revenues of $2.5 billion

– Looking for Q2 adjusted earnings of $3.80 per share; reported earnings of $3.71 per share

ADVERTISEMENT

– Lam Research shares gained 66% since the beginning of 2019; gained further during Wednesday’s after-hours sesson

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

ADVERTISEMENT